Merck pulls 2026 notes from NYSE listing
Alpha Vantage · Stock Titan · · AI-summarised by FinFlash
Merck & Co.'s 1.875% notes due 2026 are being voluntarily withdrawn from listing and registration on the New York Stock Exchange. The NYSE has complied with its rules to strike the class, and Merck met the requirements for withdrawal. A Form 25 filing removes the notes from public trading oversight under Section 12(b) of the Securities Exchange Act.
Understand the context
Published information may change. Summaries can contain errors; check the original source. Educational information only, not investment advice.